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Binding studySpectrin and ankyrin are the key components of the erythrocyte cytoskeleton. The recently published crystal
structure of the spectrin–ankyrin complex has indicated that their binding involves complementary charge
interactions as well as hydrophobic interactions. However, only the former is supported by biochemical
evidence. We now show that nonpolar interactions are important for high afﬁnity complex formation,
excluding the possibility that the binding is exclusively mediated by association of distinctly charged
surfaces. Along these lines we report that substitution of a single hydrophobic residue, F917S in ankyrin,
disrupts the structure of the binding site and leads to complete loss of spectrin afﬁnity. Finally, we present
data showing that minimal ankyrin binding site in spectrin is formed by helix 14C together with the loop
between helices 15 B/C.: +49 351 210 1209.
ll rights reserved.© 2010 Elsevier B.V. All rights reserved.1. Introduction
During its 120-day life span, an erythrocyte circulates many times
through the human body, often being squeezedwhen passing through
capillaries, which may have a diameter one fourth that of the red cell.
Key to maintaining the shape, structural integrity and remarkable
mechanical stability is the fact that these cells possess a robust
membrane skeleton of spectrin and actin. These proteins form a dense
proteinaceous network, which is markedly different from the typical
cytoskeletal systems [1–3]. Here the red cell skeleton is attached to
the membrane bilayer via integral membrane proteins and direct
interactions with lipids [4–6]. Erythrocytes with defects in the
spectrin-based skeleton lose their shape and stability, as seen in
hemolytic anemias in humans or mice [7–9]. One of the most studied
erythrocyte spectrin–membrane interactions is that of spectrin–
ankyrin binding [10,11]. Crystal structures with both spectrin/ankyrin
binding domains and the complete complex have identiﬁed charged
surfaces as being key to this interaction [12]. In a series of elegant
biochemical studies, the binding surface of beta-spectrin was
localized to helix 14C (1773–1788) and 15 B/C loop residues
(1865–1867) [12–14]. Additionally, the ankyrin-binding site has a
very important inter-repeat kink, that is required for complex
formation [12,14]. The complementary surface on ankyrin is formed
by the DAR sequence (920–922) [15], followed by residues 944–946
that interact directly with the 15 B/C loop [12]. Although it has beenproposed that spectrin–ankyrin binding involves both complementa-
ry charge interactions as well as hydrophobic interactions, only the
former is, thus far, supported by biochemical evidence.
Here we assessed the role of hydrophobic interactions in spectrin–
ankyrin binding. By evaluating binding under various salt and pH
conditions, we show that the interactions between the complemen-
tary surfaces of ankyrin and spectrin exclude the possibility that
binding is exclusively mediated by interactions of distinctly charged
surfaces. Interestingly, screening of single point mutations in the ZU5
domain of ankyrin revealed a crucial role of phenylalanine at position
917, as substitutionwith serine at this position abrogated the ability of
GFP-AnkSBD (spectrin-binding domain of ankyrin) to bind spectrin.
Finally, consistent with a recent proposal [13], we present evidence
indicating that helices 14 A/B of beta spectrin are not involved in
ankyrin binding.2. Materials and methods
2.1. Cloning, expression and puriﬁcation of His(6)GFP-AnkSBD fragment
and its mutants
AnkSBD (909–1050) ankyrin fragment was previously identiﬁed
as a minimal spectrin binding fragment [16]. It was cloned into
pRSETC expression vector followed by Green Fluorescent Protein
obtained from the pEGFP-C1. His(6)GFP–AnkSBD construct was
ampliﬁed in XL1-Blue E. coli and positively screened plasmids were
sequenced and transferred into expression BL21(DE3)pLysS E. coli
strain using a standard protocol.
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Mutagenesis Kit (Stratagene). The PCR products were stored in E.
coli strain XL1-Blue. The resulting mutant cDNAs were sequenced to
verify the mutations. Plasmids were then transferred into BL21(DE3)
pLysS cells for expression of the proteins.
Overexpressed proteins were puriﬁed using Talon® resin as
described previously [16]. Purity and concentration of His(6)GFP-
AnkSBD proteins were determined using a Cary 1E spectrophotom-
eter employing extinction coefﬁcient parameters determined for each
protein. Purity and concentrationwere also estimated from coomassie
stained SDS/PAGE on 10% gels.
2.2. Labeling of proteins
Human erythrocyte spectrin was puriﬁed by extraction of
erythrocyte ghosts with low-ionic-strength buffer at 37 °C and
separated by gel ﬁltration on a Sepharose 4B column (Sigma Aldrich),
as described [17]. Puriﬁed erythrocyte spectrin, or spectrin fragments
(ankyrin-binding domain of spectrin) were ﬂuorescently labeled
using tetramethylrhodamine-5-maleimide, which reacts with thiol
groups on proteins to give thioether. Labeling was performed
according to the manufacturer's directions. Labeling stoichiometry
was determined using a molar extinction coefﬁcient for rhodamine of
88430/55350 at 541/570 nm. Labeling efﬁciency was at least 80%.
Puriﬁed erythrocyte spectrin SpAnkBDΔ15BC fragment was ﬂuores-
cently labeled using rhodamine isothiocyanate (RITC), as described
previously [18].
2.3. CD analysis
CD measurements were performed on a JASCO CD spectrometer,
using a thermostat-controlled cell with 0.1 cm path length, from 20 to
80 °C in 0.1 °C increments, at 220 nm. Ellipticity (θ: in degrees) values
from CD spectra were converted intomolar residue ellipticity ([θ]M: in
degrees cm2 dmol−1) value.
2.4. FRET assay
Either tetramethylrhodamine-5-maleimide or rhodamine isothio-
cyanate labeled spectrin fragments were used at a concentration of
0.5 μMwith ascending concentrations of His(6)GFP-AnkSBD fragment
or its mutants in a total volume of 1 ml (150 mM NaCl, 20 mM Tris–
HCl, pH 7.4). After 20 min incubation at room temperature, rhoda-
mine and GFP ﬂuorescence were measured in a Cary Eclipse (Varian)
Spectroﬂuorimeter with 488 nm excitation wavelength for GFP tag
protein and 576 nm emission wavelength for rhodamine. Standard
curves for GFP tagged ankyrin constructs and for rhodamine labeled
spectrin fragments were made independently.
2.5. EIA (electrochemiluminescence immunoassay)
Spectrin fragments (25 ng/μl) were adsorbed on to a high bind
carbon electrode surface (MesoScale Discovery) (1 h, 23 °C), the rest
of the surface was blocked with 0.1% fat free BSA (1 h, 23 °C). The
surface was then washed three times with 150 mMNaCl, 20 mM Tris–
HCl pH 7.5, and subsequently, the deﬁned concentrations of proteins
were added to each well. Binding was allowed for 2 h at 23 °C
(different conditions of binding are stated along the paper together
with the results). The wells were again washed and primary anti-GFP
antibody was applied (ROCHE, Rabbit anti-GFP, 1 μg/ml, 23 °C, 1 h).
The wells were again washed and secondary antibody (goat anti-
rabbit-STAG) was added (1 μg/ml, 23 °C, 1 h). The wells were washed
and reading buffer was added (MSD surfactant free reading buffer). As
a background, both primary and secondary antibodies binding to BSA
were used. Data were acquired on a SECTOR Imager 6000.2.6. Sedimentation assay
Spectrin-binding activity of AnkSBD polypeptide was determined
in an experiment in which a metal afﬁnity resin (Talon) saturated
with a His-tagged AnkSBD, or its mutants, was incubated with
increasing concentrations of RITC-labeled erythrocyte spectrin in the
test buffer (20 mMTris–HCl, 150 mMNaCl, pH 7.4) for 30 min at room
temperature. The resin was then pulled down at 2000×g for 5 min,
resuspended in 50 mM imidazole in the test buffer, and centrifuged
again. Bound protein was solubilized with 0.1% SDS in the test buffer.
The amount of bound, labeled spectrin in the SDS extract was
determined using a Varian Cary Eclipse Spectroﬂuorimeter. Control
experiments were performed using the Talon resin equilibrated in the
test buffer and incubated with corresponding amounts of RITC-
labeled spectrin. Bound values were obtained by subtracting control
values from those for spectrin bound to the resin saturated with
AnkSBD.
2.7. Data analysis
The recorded data were analyzed in GraphPad Prism 5.0 software
using One site (total and nonspeciﬁc) binding algorithm.
2.8. Modeling of ankyrin (AnkSBD) and spectrin (SpAnkBD) constructs
Structural models corresponding to AnkSBD and SpAnkBD con-
structs were generated by homology modeling using MODELLERv9
[19]. For each construct, ﬁve models with hydrogen atoms were
generated and ranked according their ﬁt to the structure of human
erythroid spectrin and ankyrin (PDB ID 3KBU). Multiple templates
(3KBU and 3EDV)were used for SpAnkBD in order to generate the 15–
16 repeat. AnkBD was calculated from a single template (3KBU).
Protonation states for different pH values and electrostatic surface
charges were calculated within PROPKA [20] and APBS [21],
respectively, and visualized in PyMOL.
3. Results
3.1. Binding studies of ankyrin and spectrin
To determine the minimal spectrin binding surface required for
full ankyrin binding activity, the binding afﬁnities of various spectrin
fragments were recorded, using two independent approaches. In an
EIA assay (Fig. 1), using unlabeled ankyrin-binding domain of β
spectrin (AnkBDn—for graphical representation of the fragments refer
to Fig. 1) and its truncated form (SpAnkBD), we obtained similar KD
values for both fragments. These values are very similar to earlier data
reported by us [16] and by others [22,23]. In a parallel assay, we
measured ﬂuorescence (Forster) resonance energy transfer (FRET)
between the rhodamine-maleimide-labeled ankyrin-binding domain
of SpAnkBD or SpAnkBDΔ15BC fragments and GFP-AnkSBD (Fig. 1).
We observed signiﬁcant differences (pb0.05) in binding afﬁnities
between the fragments. These results demonstrated that residues
comprising helices 14A and 14B are irrelevant for the high-afﬁnity
complex formation—a ﬁnding, which is in agreement with the
previously reported data [13,14]. Moreover, the results obtained
from the SpAnkBDΔ15BC fragment encompassing residues 1638–
1845, which lacks the 15 B/C-loop, further conﬁrm the importance of
loop residues in proper binding, as suggested previously [13–15].
3.2. Dependence on binding conditions
It has been suggested that the interface between spectrin and
ankyrin is formed by ionic interactions between charged residues on
the respective proteins [12,24]. If true, this would suggest that high
salt conditions would be best for spectrin–ankyrin dissociation. In
Fig. 1. Amino acid residues within loop 15B/C are important for proper binding, whereas residues of helices 14A/B are not. Binding of AnkSBD to full length ankyrin-binding domain
of spectrin (AnkBDn) and its truncated mutants (SpAnkBD, SpAnkBDΔ15BC) was assessed. The EIA results revealed that SpAnkBD (B) binds to AnkSBDwith similar characteristics as
the full length ankyrin-binding domain (A) (KD and Bmax—details shown in table below the graphs). In a separate FRET assay, the observed KD values for SpAnkBDΔ15B/C (C) were
signiﬁcantly higher (pb0.05) than for SpAnkBD (D). ΔF is the relative increase of ﬂuorescence signal of rhodamine labeled spectrin fragments in comparison to control (ﬂuorescence
of spectrin fragment in assay buffer). The measured KD for SpAnkBD was consistent between both assays. Statistical analysis was performed using paired t-test. (n.s., not signiﬁcant,
*p-valueb0.05). (E) The colored bars depict the schematic representation of the various spectrin fragments used in the assays with respect to their length and helical repeats.
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of higher NaCl concentrations (50–500 mM NaCl) (Fig. 2). In fact, the
routine method of spectrin isolation, which has been known for more
than three decades, uses low ionic strength solutions to extract
spectrin from the erythrocyte membrane [25,26]. To determine the
effect of ionic strength on spectrin–ankyrin binding afﬁnity, a series of
binding assays was performed. Measurements made in low salt
buffers (0–20 mM NaCl) showed a moderate (three-fold) increase in
the KD value of this interaction when compared to the “control” buffer
containing 150 mM NaCl (Fig. 2). These changes, although signiﬁcant
(pb0.01), were not dramatic, which was rather unexpected, given the
established protocols for spectrin extraction from erythrocyte
membranes. In spite of these results, it was clear that temperature
was a key factor in dissociation of the complex, as the actual
procedure included using low ionic strength solutions at temperature
of 37 °C [25,26]. However, performing the binding assay at 37 °C in
corresponding salt conditions gave ambiguous results due to protein
instability in low salt conditions (Fig. 2 lower panel). The observed
protein instability was clearly time dependent and rather irreversible
(not shown). It remains unclear, therefore, whether similar domain
instability occurs during spectrin isolation. The overall results suggest
that non-ionic interactions are of substantial importance.
To further estimate the contribution of ionic interactions for the
spectrin–ankyrin association, binding of GFP-AnkSBD to SpAnkBD
was performed at various pHs using EIA. Increasing the pH to 9.0 did
not signiﬁcantly change the binding. On the other hand, a decrease in
pH had a signiﬁcant effect on the binding. At pH 5.0 the interactions
were greatly decreased, KDN122 nM, while at pH 6.0 far less dramatic
changes in binding afﬁnity were observed (Fig. 3). Calculations using
PyMOL showed that the surface of SpAnkBD in the 15th triple helical
repeat was essentially positively charged at pH 5.0, but was negatively
charged at pH 9.0. However, the changes in surface charge did not
correspond to the binding site region (Supplementary Figure 1). The
charges of residues comprising the potential binding site of ankyrin
were conserved at either pH (Supplementary Figure 1). A further
investigation of the stability of the studied fragments revealed thatSpAnkBD was unstable at low pH, which was used in the aforemen-
tioned experiments. Therefore the observed loss of binding is most
probably caused by instability of the SpAnkBD fragment. Generally,
the results presented above indicate that although charged residues of
both spectrin and ankyrin are important components of complex
formation, these residues do not explain all potential binding in the
interface of the complex.
3.3. Point mutations in ZU5 domain
Based on our analysis of binding data and the binary complex
crystal structure, we introduced point mutations within blocks of four
hydrophobic amino acid residues within the ZU5 domain. All mutants
were tested for SpAnkBD fragment binding afﬁnity using both FRET
and EIA. Mutations of phenylalanine 913 and 917 affected binding of
SpAnkBD; substitution of F913S led to an increase in KD, while in the
case of F917S the binding to SpAnkBD fragment as well as to isolated
and TRITC-labeled native αIβI spectrin was almost completely
abrogated (Fig. 4), indicating that this residue was crucial for
appropriate spectrin–ankyrin interactions. According to the crystal
structure the side chain of F917 is buried inside the core of the
domain. Circular dichroism (CD) analysis conﬁrmed that the loss of
binding could not be caused by the instability of the mutant. The
actual Tm of the mutant was even higher than that for the WT.
However, the recorded CD spectra showed that F917S mutation
results in some changes in the secondary structure (not shown). It
should be noted that the F917 residue is part of the same β-sheet as
the 920DAR922 sequence previously reported as being crucial for
spectrin–ankyrin interactions [15]. Therefore, though the two phe-
nylalanines (913Ank, 917Ank) do not seem to be directly involved in
formation of the binding interface, it is plausible that their side chains
are important parts of the hydrophobic core of the domain and that
they are involved in the proper orientation of the binding site. This
would indicate that there is a strong need for a correct conformation
of the corresponding binding sites in both ankyrin as well as in
spectrin (as shown previously [12,14]).
Fig. 2. Binding assay for GFP-AnkSBD and SpAnkBD performed at room temperature (top panel) or at 37 °C (bottom panel) at various NaCl concentrations. The binding of GFP-
AnkSBD at 37 °C in no salt conditions showed strongly decreased binding capacity due to protein instability, as observed by a drop in Bmax. Binding afﬁnities were tested using FRET
or EIA and statistical analyses were performed using paired t-test. (n.s.not signiﬁcant, *p-valueb0.05, ***p-valueb0.001).
2087A. Kolondra et al. / Biochimica et Biophysica Acta 1798 (2010) 2084–20894. Discussion
It has been suggested that the major factor responsible for proper
ankyrin–spectrin binding is the presence of complementary charged
surfaces on respective proteins [24]. These suggestions come from
known clinical cases of anemia, which were caused by various point
mutations of hydrophilic residues within the ankyrin-binding domain
of spectrin. The data were further supported by biochemical studies
on point mutants of spectrin, where again, hydrophilic residues were
mutated [13,14]. Not surprisingly, these results were conﬁrmed by the
crystal structure of the spectrin–ankyrin complex, which showed the
presence of these residues in the actual binding interface [12].
However, as we show here in a series of experiments at different salt
concentrations, the binding afﬁnity decreases at low salt concentra-
tion (0 mMNaCl) and remains unchanged at higher salt concentration
(500 mM NaCl) when compared to the control (150 mM NaCl)
(Fig. 2). Ionic interactions are usually easily disrupted in high salt,
which is not the case here. This ﬁnding, together with the fact that
spectrin is actually extracted from the membrane at low ionic
strength, indicates signiﬁcant importance of nonpolar residues in
the binding. On the basis of the ionic strength and pH effect on the
interaction, we conclude that hydrophilic interactions play anFig. 3. Spectrin–ankyrin interactions are susceptible to low pH. Equilibrium dissociation con
were tested using EIA and statistical analyses were performed using paired t-test. n.s.—notimportant role, although they cannot be the only forces that maintain
the spectrin–ankyrin complex, because at high ionic strength we do
not observe prominent changes in binding afﬁnity. To further
investigate this issue, we analyzed point mutants of AnkSBD, where
highly hydrophobic phenylalanines were substituted by serine
residues. The obtained results indicate that a single point mutation,
F917S, localized in the N terminal region of the ZU5 domain in a
hydrophobic block (916SFMV919), abrogated binding of this domain
to SpAnkBD or TRITC-labeled spectrin. According to the crystal
structure, the side chain of F917 is buried inside the structure of
AnkSBD and, as such, does not make direct contact with spectrin. Also,
the substitution of F with S does not lead to increased protein
instability (Fig. 5). Therefore, it is difﬁcult to imagine how this
particular residue could have such a crucial role for the proper
binding. There are several hydrophobic residues in both ankyrin and
spectrin that could be involved in direct interactions (L914Ank,
V915Ank, M918Ank, T950Ank; A1780Sp, L1785Sp, T1788Sp, L1792Sp,).
One possible explanation is that F917, which is localized at the center
of a dense hydrophobic core, interacts with F913 such that the side
chains of the F917 and F913 are involved in a T-shaped π–π
interaction that stabilizes the protein shape in this region [27]. The
replacement of the phenylalanine by a serine could disrupt the properstants for GFP-AnkSBD and SpAnkBD at various pHs were determined. Binding afﬁnities
signiﬁcant, **p-valueb0.01, ***p-valueb0.001.
Fig. 4. Hydrophobic residues F913 and F917 are important for proper ankyrin–spectrin complex formation. Binding curves and equilibrium dissociation constants of SpAnkBD or its
point mutants. The binding afﬁnity was tested using EIA (A) or Sedimentation assay (B). The table shows the summary of the obtained data. Statistical analysis was performed using
paired t-test: **pN0.01: ***pN0.001. (C) CD thermal denaturation curves (fraction unfolded versus temperature, left) showed that the F917S mutation had a stabilizing effect on
folding. Bar graph (inset) shows the average thermal stability of the proteins (the error bars correspond to the standard error).
Fig. 5. Details of the ankyrin–spectrin binding interface. Ankyrin and spectrin are
colored in yellow and blue, respectively. Residues F913Ank and F917Ank (orange) are
buried within the hydrophobic core of the protein. Other hydrophobic residues at the
interface (A1780Sp, T1788Sp, T1785Sp, L1792Sp for spectrin and L914Ank, V915Ank,
M918Ank and T950Ank) are displayed with sticks. The ﬁgure was prepared using
coordinates of the spectrin–ankyrin complex (PDB ID 3KBU) [12].
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contains a beta-turn and a beta-sheet could adopt a different
orientation, and, as a consequence, lose the ability to bind spectrin.
This in fact would indicate that not only spectrin adapts a unique
conformation in the ankyrin-binding site [12,14] but that also ankyrin
has a very deﬁned structure that is able to recognize the site of
interaction.
The results presented here suggest that both hydrophilic and
hydrophobic forces are engaged in binding between spectrin and
ankyrin. We conclude that the major interaction site for ankyrin
binding lies within helix 14C and that residues in the 15 B/C loop act
as additional support. This conclusion is, in principle, in agreement
with recently published data [12]. Our results provide also additional
evidences on the role of proper ﬁt between spectrin and ankyrin. In
this respect, F917Ank is crucial for the proper orientation of the of the
spectrin binding site in ankyrin as replacement of F917Ank with a
serine residue abolished spectrin-binding activity.
Supplementarymaterials related to this article can be found online
at doi:10.1016/j.bbamem.2010.07.024.
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